Doxycycline
LeDoxy2015_Mali
Phase 3 small_molecule completed
Quick answer
Doxycycline for Lymphedema is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 3 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Lymphedema
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed